Skip to main content
. 2020 Nov 18;10:20121. doi: 10.1038/s41598-020-76934-1

Table 1.

Demographics at baseline.

Total
(n = 100)
Morphine
(n = 54)
Placebo
(n = 46)
p-value
Age (Mean ± SD) 28.06 ± 6.82 28.50 ± 6.93 27.54 ± 6.73 0.48
Sex, n (%) 0.35
Female 58 (58.0%) 29 (53.7%) 29 (63.0%)
Race, n (%) 0.42
Caucasian 45 (45.0%) 24 (44.4%) 21 (45.7%)
African American 37 (37.0%) 20 (37.0%) 17 (37.0%)
Asian 11 (11.0%) 4 (7.4%) 7 (15.2%)
More than one race 3 (3.0%) 3 (5.6%) 0 (0%)
Other/decline to state 4 (4.0%) 3 (5.6%) 1 (2.2%)
Ethnicity, n (%) 0.13
Hispanic 17 (17.0%) 12 (22.2%) 5 (10.9%)
Education, n (%) 0.27
High school/GED 6 (6.0%) 4 (7.5%) 2 (8.3%)
Some college/current student 27 (27.0%) 9 (17.0%) 18 (39.2%)
College graduate 45 (45.0%) 27 (50.9%) 18 (39.1%)
Technical school graduate 1 (1.0%) 1 (1.9%) 0 (0.0%)
Advanced degree 20 (20.0%) 12 (22.7%) 8 (17.4%)
Employment status, n (%) 0.07
Student 35 (35.0%) 22 (41.5%) 13 (28.2%)
Employed 48 (48.0%) 21 (39.6%) 27 (58.7%)
Unemployed 15 (15.0%) 10 (18.9%) 5 (10.9%)
Homemaker 1 (1.0%) 0 (0%) 1 (2.2%)

Values represent mean (percent of total) for demographics of participants. T-test (for continuous variables) and chi-square (categorical variables) test was used to examine differences in morphine vs. placebo conditions.